Jonathan Robert Behr

age ~43

from Newton, MA

Get Report

Also known as:

Jonathan R Behr
Jonathan R Bettr

Phone and address:: 102 Parker St, Newton, MA 02459

Connected to:

Jonathan Behr Phones & Addresses

102 Parker St, Newton Center, MA 02459
Newton, MA
Cambridge, MA
Boston, MA
Potomac, MD

Us Patents

Methods, Kits, And Compositions For Administering Pharmaceutical Compounds
view source
US Patent:

20100298760, Nov 25, 2010
Filed:

Oct 21, 2008
Appl. No.:

12/741338
Inventors:

Bernat Olle - Cambridge MA, US
Daphne Zohar - Boston MA, US
Jonathan Behr - Boston MA, US
David Steinberg - Milton MA, US
International Classification:

A61M 5/00
A61N 5/067
A61B 17/34
US Classification:

604 20, 604 22, 604 46
Abstract:

The invention features methods, kits, and compositions for administering pharmaceutical compounds using microdermabrasion particles.

Phenazine Derivatives And Uses Thereof
view source
US Patent:

20100330156, Dec 30, 2010
Filed:

Mar 22, 2010
Appl. No.:

12/729083
Inventors:

Jun O. LIU - Clarksville MD, US
Yunzhao REN - Timonium MD, US
Fan PAN - Baltimore MD, US
Curtis R. CHONG - Honolulu HI, US
Reinhold PENNER - Honolulu HI, US
Jonathan R. BEHR - Cambridge MA, US
Assignee:

THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:

A61K 31/498
A61K 9/127
A61P 25/28
A61P 25/00
A61P 3/10
A61P 37/00
A61P 1/04
A61P 37/06
US Classification:

424450, 514250
Abstract:

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Methods Of Diagnosing And Treating Microbiome-Associated Disease Using Interaction Network Parameters
view source
US Patent:

20120149584, Jun 14, 2012
Filed:

Aug 20, 2010
Appl. No.:

13/391352
Inventors:

Bernat Olle - Cambridge MA, US
Jonathan Robert Behr - Boston MA, US
W. Edward Martucci - Norwood MA, US
Daphne Zohar - Boston MA, US
International Classification:

C40B 20/00
G06G 7/58
C12Q 1/68
US Classification:

506 2, 435 612, 703 11
Abstract:

Methods of diagnosing and treating microbiome-associated disease or improving health using interaction network parameters are provided. Methods are provided to analyze interaction networks between microbes, and between microbes and the host, to determine important (e.g. “highly-connected”) organisms or molecules as determined by various network parameters. Methods are provided including and beyond correlation to use these “highly-connected” organisms or molecules as targets for modulation or as therapeutic agents to improve health.

Monitoring Heparin By Microelectronic Devices
view source
US Patent:

20070212786, Sep 13, 2007
Filed:

Sep 29, 2006
Appl. No.:

11/540695
Inventors:

Scott Manalis - Cambridge MA, US
Tzu Loh - Watertown MA, US
Michel Godin - Somerville MA, US
Nebojsa Milovic - Basel, CH
Jonathan Behr - Cambridge MA, US
Aarthi Chandrasekaran - Cambridge MA, US
Ram Sasisekharan - Cambridge MA, US
International Classification:

G01N 33/86
US Classification:

436069000
Abstract:

In one aspect, the present invention provides a device and method for real-time, direct detection of heparin in buffer and in serum comprising a microfluidic field-effect device as an affinity biosensor. The sensor is based on an electrolyte-insulator-silicon structure, and is manufactured by a standard high-yield silicon microfabrication process. The binding of heparin to the sensor surface induces a change in the insulator-electrolyte surface potential, which is measured as a change in sensor capacitance. To ensure the binding selectivity, protamine and antithrombin III are used as affinity probes.

Mucoadhesive Devices For Delivery Of Active Agents
view source
US Patent:

20180098934, Apr 12, 2018
Filed:

Dec 12, 2017
Appl. No.:

15/839132
Inventors:

- BOSTON MA, US
- OAKLAND CA, US
David Adam STEINBERG - Milton MA, US
Rodney PEARLMAN - El Granada CA, US
Howard Brian ROSEN - Woodside CA, US
Robert Samuel LANGER - Newton MA, US
Jonathan Robert BEHR - Cambridge MA, US
Samir Suresh MITRAGOTRI - Santa Barbara CA, US
International Classification:

A61K 9/00
A61K 9/20
A61K 38/23
A61K 38/28
Abstract:

Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.

Mucoadhesive Devices For Delivery Of Active Agents
view source
US Patent:

20170196800, Jul 13, 2017
Filed:

Nov 18, 2016
Appl. No.:

15/356096
Inventors:

- BOSTON MA, US
- OAKLAND CA, US
David Adam STEINBERG - Milton MA, US
Rodney PEARLMAN - El Granada CA, US
Howard Brian ROSEN - Woodside CA, US
Robert Samuel LANGER - Newton MA, US
Jonathan Robert BEHR - Cambridge MA, US
Samir Suresh MITRAGOTRI - Santa Barbara CA, US
International Classification:

A61K 9/00
A61K 38/23
A61K 9/20
A61K 38/28
Abstract:

Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.

Mucoadhesive Devices For Delivery Of Active Agents
view source
US Patent:

20160101056, Apr 14, 2016
Filed:

Sep 28, 2015
Appl. No.:

14/867229
Inventors:

- BOSTON MA, US
- OAKLAND CA, US
David Adam STEINBERG - Milton MA, US
Rodney PEARLMAN - El Granada CA, US
Howard Brian ROSEN - Woodside CA, US
Robert Samuel LANGER - Newton MA, US
Jonathan Robert BEHR - Cambridge MA, US
Samir Suresh MITRAGOTRI - Santa Barbara CA, US
International Classification:

A61K 9/20
A61K 38/28
Abstract:

Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.

Mucoadhesive Devices For Delivery Of Active Agents
view source
US Patent:

20150174076, Jun 25, 2015
Filed:

Jun 14, 2013
Appl. No.:

14/407220
Inventors:

- Boston MA, US
- Oakland CA, US
David Adam Steinberg - Milton MA, US
Rodney Pearlman - El Granada CA, US
Howard Brian Rosen - Woodside CA, US
Robert Samuel Langer - Newton MA, US
Jonathan Robert Behr - Cambridge MA, US
Samir Suresh Mitragotri - Santa Barbara CA, US
International Classification:

A61K 9/20
A61K 47/38
A61K 38/23
A61K 47/36
A61K 31/352
A61K 38/28
Abstract:

Described herein are systems and methods for transmucosal delivery of active agents. In some embodiments, a system may comprise one or more mucoadhesive devices configured for release of an active agent.

Resumes

Partner

view source

Location:

102 Parker St, Newton, MA 02459

Industry:

Venture Capital & Private Equity

Work:

Dementia Discovery Fund
Partner
Diasome Pharmaceuticals, Inc. Jul 2017 - Jul 2019
Board Observer
Semma Therapeutics May 2017 - Dec 2017
Board Observer
Partners Healthcare Dec 2013 - Dec 2016
Executive In Residence and Market Sector Leader
Exosome Diagnostics Aug 2015 - Dec 2016
Board Observer

Education:

Massachusetts Institute of Technology 2002 - 2007
Doctorates, Doctor of Philosophy, Biological Engineering Rice University 1998 - 2002
Bachelors, Bachelor of Science, Bioengineering

Skills:

Biotechnology
Start Ups
Venture Capital
Lifesciences
Business Development
Drug Discovery
Business Strategy
Strategy
Entrepreneurship
Pharmaceutical Industry
Life Sciences
Biopharmaceuticals
Intellectual Property
Technology Transfer
Deal Sourcing
Licensing
Clinical Development
New Business Development
Medical Devices
Due Diligence
Protein Chemistry
Technology Evaluation
Start Up Ventures
Patent Law
New Venture Development
Bioengineering
Patents
Drug Development
Oncology
Venture Management
Biotechnology Industry
Drug Delivery
Venture Financing
Research and Development
Deal Making
New Venture Creation
Technology Development
Intellectual Property Strategy
Operations
Operations Management
Drug Safety
Personalized Medicine
Commercialization
Management

Vice President Of New Ventures At Enlight Biosciences

view source

Position:

Vice President of New Ventures at Enlight Biosciences, Chief Operating Officer at Entrega, Inc.

Location:

Greater Boston Area

Industry:

Venture Capital & Private Equity

Work:

Enlight Biosciences - Boston since Feb 2013
Vice President of New Ventures
Entrega, Inc. - Boston since Jan 2012
Chief Operating Officer

Skills:

Venture Capital
New Venture Development
Venture Management
Deal Sourcing
Technology Evaluation
Licensing
Business Strategy
Bioengineering
Biotechnology
Pharmaceutical Industry
Biotechnology Industry
Start-up Ventures
Start-ups
Business Development
New Business Development
Lifesciences
Intellectual Property
Drug Discovery
Technology Transfer
Medical Devices
Patents
Due Diligence
Deal Making
New Venture Creation
Technology Development
Intellectual Property Strategy
Operations
Life Sciences
Operations Management
Drug Development
Drug Delivery
Drug Safety
Oncology
Personalized Medicine

Name / Title

Company / Classification

Phones & Addresses

Jonathan Behr
Director

Entrega Inc.
Venture Capital & Private Equity · Commercial Physical Research

500 Boylston St SUITE 1600, Boston, MA 02116

Jonathan Behr
Director

Enlight Biosciences
Biotechnology · Venture Capitalist

500 Boylston St SUITE 1600, Boston, MA 02116